PlasmaTech Biopharmaceuticals’ Announces $10 Million Private Placement
MarketWatch Pursuant to a registration rights agreement with the investors, the Company has agreed to file a registration statement with the SEC covering the resale of the shares of common stock and shares issuable upon exercise of the warrants within 30 days of … |